Publicly Traded Cannabis Gets Real on Valuations

4y
2m read
Summary

The feeding frenzy quickly moved from the OTC Pink Marketplace and FINRA bulletin board to Canadian stock markets. As soon as legalization became real in a few states, penny stock shells, companies that failed as a mining company that then became a failed software company suddenly became cannabis companies. Exemplify by the reasons discussed in the below article, MedMen Enterprises and PharmaCann terminating the proposed acquisition that was trumpeted as the largest US cannabis company once valued at $682 million. Stock markets are increasingly skittish over volatility and overdue recession fears in general and legal cannabis companies are challenged by looming supply and demand imbalance. Attention to business fundamentals is tamping down valuations. https://www.cnn.com/2019/10/10/business/medmen-pharmacann-blockbuster-cannabis-deal-falls-apart/index.html Investing fads in emerging industries often follow a typical path and cannabis stock has done so at a rapid pace.

Article PreviewStock market bandwagon rides, no matter how good usually come to an end.  Hopefully, investors get where they thought they were going rather than crashing with all aboard.  I often tell clients that I am a professional pessimist and it appears that the irrational exuberance for publicly-traded cannabis stocks is coming to an end. Exemplify by the reasons discussed in the below article, MedMen Enterprises and PharmaCann terminating the proposed acquisition that was trumpeted as the largest US cannabis company once valued at $682 million.  Harborside Inc., has also backed off on California acquisitions of cultivators, Airfield Supply and Agris...

Read the full article @ Cannabis Law Report